Lipodystrophy: Lack of agreement on definition and etiology presents a challenge to research and therapy

AIDS Reader

Volumn 12, Issue 10, 2002, Pages 438-442

  Moyle, Graeme ^a  

^a CHELSEA AND WESTMINSTER HOSPITAL   (United Kingdom)

Author keywords

Case definition; HIV AIDS; Lipodystrophy; Mitochondria; Tumor necrosis factor

Indexed keywords

CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR4; COMPLEMENT COMPONENT C3; CYCLOOXYGENASE 2; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR; TUMOR NECROSIS FACTOR ALPHA;

ANTIGEN EXPRESSION; DRUG SAFETY; DUAL ENERGY X RAY ABSORPTIOMETRY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOPATHOGENESIS; LIPODYSTROPHY; PREVALENCE; REVIEW; RISK ASSESSMENT; RISK FACTOR;

ANTI-HIV AGENTS; DNA, MITOCHONDRIAL; HIV-ASSOCIATED LIPODYSTROPHY SYNDROME; HUMANS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0036798787     PISSN: 10530894     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (18)

1. Carr A, Samaras K, Burton S, et al. A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors. AIDS. 1998;12:F51-F58.
2. Moyle G. The switching spiral: a triumph of hope over benefit? AIDS Reader. 2002;12:147-150.
3. Marrakech classification of HIV lipodystrophy. Presented at: European Symposium on Lipodystrophy and HIV Infection; April 24-25, 2000; Marrakech, Morocco.
4. The HIV Lipodystrophy Case Definition Study Group. A case definition study of lipodystrophy in human immunodeficiency virus-infected adults. JAMA. In press.
5. Grunfeld C. Basic science and metabolic disturbances. In: Program and abstracts of the XIV International AIDS Conference; July 7-12, 2002; Barcelona, Spain. Abstract TuOr158.
6. Lichtenstein KA, Delaney KM, Ward DJ, et al. Changes in HIV-associated fat maldistribution over time. Antivir Ther. 2000;5(suppl 5):9.
7. Moyle G. Mitochondrial toxicity hypothesis for lipoatrophy: a refutation. AIDS. 2001;15:413-415.
8. Ionescu G, He Q, Engelson ES, et al. Acylation stimulating protein (ASP) and tumor necrosis factor (TNF) production in subcutaneous adipose tissue of HIV-infected patients with and without lipodystrophy. In: Program and abstracts of the XIV International AIDS Conference; July 7-12, 2002; Barcelona, Spain. Abstract WePeA5794.
9. Ware LJ, Morelese J, Burdge G, et al. Differences in postprandial lipid metabolism in patients with PI-associated and NRTI-associated lipodystrophy. In: Program and abstracts of 2nd International Workshop on Adverse Drug Interactions and Lipodystrophy; September 13-15, 2000; Toronto. Abstract O20.
10. Johnson J, Albu JB, Engelson ES, et al. Studies of subcutaneous adipose tissue (SAT) in HIV+ subjects with and without lipodystrophy. In: Program and abstracts of the XIV International AIDS Conference; July 7-12, 2002; Barcelona, Spain. Abstract ThPeB7357.
11. Shikuma CM, Hu N, Milne C, et al. Mitochoridrial DNA decrease in subcutaneous adipose tissue of HIV-infected individuals with peripheral lipoatrophy. AIDS. 2001;15:1801-1809.
12. Ledru E, Christeff N, Patey O, et al. Alteration of tumor necrosis factor-alpha T-cell homeostasis following potent antiretroviral therapy: contribution to the development of human immunodefficiency virus-associated lipodystrophy syndrome. Blood. 2000;95:3191-3198.
13. Tremblay CL, Giguel F, Olson D, et al. Human adipocytes and pre-adipocytes are not permissive to HIV-1 infection in vitro. In: Program and abstracts of the XIV International AIDS Conference; July 7-12, 2002; Barcelona, Spain. Abstract ThPeB7336.
14. Hazan U, Romero IA, Cancello R, et al. Human adipose cells express CD4, CXCR4, CCR5 and receptors: a new target cell type for the immunodefficiency virus type-1? FASEB J. 2002;16:1254-1256.
15. Rodriguez de la Concepcion ML, Iglesias R, Yubero P, et al. Uncoupling protein and brown adipocyte mitochondria as potential targets of nucleoside and non-nucleoside reverse transcriptase inhibitor-induced lipodystrophy. In: Program and abstracts of the XIV International AIDS Conference; July 7-12, 2002; Barcelona, Spain. Abstract MoPeA3007.
16. Miró O, Casademont S, López S, et al. Mitochondrial respiratory deficiencies in antiretroviral therapy-related lipodystrophy. In: Program and abstracts of the XIV International AIDS Conference; July 7-12, 2002; Barcelona, Spain. Abstract TuPeB4506.
17. Carr A, Workman C, Smith DE, et al. Abacavir substitution for nucleoside analogs in patients with HIV lipoatrophy: a randomized trial. JAMA. 2002;288:207-215.
18. Moyle GJ, Baldwin C, Gazzard BG. A randomised open label study of 3 substitution strategies in hypercholesterolemic persons virologically controlled on first line antiretroviral therapy (ART). In: Program and abstracts of the XIV International AIDS Conference; July 7-12, 2002; Barcelona, Spain. Abstract ThPeB7322.